Report Italy - Medicaments Containing Insulin But not Antibiotics - Market Analysis, Forecast, Size, Trends and Insights for 499$
Report Update Apr 15, 2024

Italy - Medicaments Containing Insulin But not Antibiotics - Market Analysis, Forecast, Size, Trends and Insights

Single report
Sent by email within 24h (Mon-Fri)
Subscription
Online access and download
from $350/month

Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.

View Pricing

Italy: Medicaments Containing Insulin Market 2024

Medicaments Containing Insulin Market Size in Italy

The Italian medicaments containing insulin market declined notably to $X in 2023, falling by X% against the previous year. Overall, consumption showed a precipitous setback. Over the period under review, the market reached the maximum level at $X in 2013; however, from 2014 to 2023, consumption remained at a lower figure.

Medicaments Containing Insulin Production in Italy

In value terms, medicaments containing insulin production contracted modestly to $X in 2023 estimated in export price. Over the period under review, production showed a relatively flat trend pattern. The most prominent rate of growth was recorded in 2013 with an increase of X% against the previous year. As a result, production reached the peak level of $X. From 2014 to 2023, production growth failed to regain momentum.

Medicaments Containing Insulin Exports

Exports from Italy

Medicaments containing insulin exports from Italy soared to X tons in 2023, with an increase of X% compared with the previous year's figure. Overall, exports continue to indicate significant growth. The most prominent rate of growth was recorded in 2020 when exports increased by X%. The exports peaked in 2023 and are likely to see steady growth in years to come.

In value terms, medicaments containing insulin exports skyrocketed to $X in 2023. In general, exports continue to indicate a significant expansion. The growth pace was the most rapid in 2013 with an increase of X% against the previous year. As a result, the exports reached the peak of $X. From 2014 to 2023, the growth of the exports failed to regain momentum.

Exports by Country

Brazil (X tons) was the main destination for medicaments containing insulin exports from Italy, accounting for a X% share of total exports. Moreover, medicaments containing insulin exports to Brazil exceeded the volume sent to the second major destination, Germany (X kg), fourfold. The third position in this ranking was held by the Czech Republic (X kg), with an X% share.

From 2012 to 2023, the average annual growth rate of volume to Brazil was relatively modest. Exports to the other major destinations recorded the following average annual rates of exports growth: Germany (X% per year) and the Czech Republic (X% per year).

In value terms, Germany ($X), the Czech Republic ($X) and the Netherlands ($X) appeared to be the largest markets for medicaments containing insulin exported from Italy worldwide, with a combined X% share of total exports.

Among the main countries of destination, Germany, with a CAGR of X%, recorded the highest rates of growth with regard to the value of exports, over the period under review, while shipments for the other leaders experienced more modest paces of growth.

Export Prices by Country

In 2023, the average medicaments containing insulin export price amounted to $X per ton, falling by X% against the previous year. In general, the export price recorded a abrupt curtailment. The pace of growth appeared the most rapid in 2013 an increase of X% against the previous year. As a result, the export price reached the peak level of $X,422 per ton. From 2014 to 2023, the average export prices failed to regain momentum.

Prices varied noticeably by country of destination: amid the top suppliers, the country with the highest price was the Netherlands ($X per ton), while the average price for exports to Brazil ($X per ton) was amongst the lowest.

From 2012 to 2023, the most notable rate of growth in terms of prices was recorded for supplies to the Czech Republic (X%), while the prices for the other major destinations experienced a decline.

Medicaments Containing Insulin Imports

Imports into Italy

For the fourth year in a row, Italy recorded decline in purchases abroad of medicaments containing insulin but not antibiotics, which decreased by X% to X kg in 2016. Overall, imports recorded a sharp descent. The smallest decline of X% was in 2015. Imports peaked at X kg in 2012; however, from 2013 to 2016, imports remained at a lower figure.

In value terms, medicaments containing insulin imports reduced notably to $X in 2016. In general, imports saw a precipitous descent. The smallest decline of X% was in 2013. Imports peaked at $X in 2012; however, from 2013 to 2016, imports failed to regain momentum.

Imports by Country

In 2016, Germany (X kg) was the main medicaments containing insulin supplier to Italy, accounting for a approx. X% share of total imports.

From 2012 to 2016, the average annual growth rate of volume from Germany stood at X%.

In value terms, Germany ($X) constituted the largest supplier of medicaments containing insulin but not antibiotics to Italy.

From 2012 to 2016, the average annual rate of growth in terms of value from Germany totaled X%.

Import Prices by Country

In 2016, the average medicaments containing insulin import price amounted to $X per kg, waning by X% against the previous year. In general, the import price saw a abrupt setback. Over the period under review, average import prices hit record highs at $X per kg in 2012; however, from 2013 to 2016, import prices remained at a lower figure.

As there is only one major supplying country, the average price level is determined by prices for Germany.

From 2012 to 2016, the rate of growth in terms of prices for Germany amounted to X% per year.

Source: IndexBox Platform

This report provides an in-depth analysis of the medicaments containing insulin market in Italy. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.

Product coverage:

  • Prodcom 21201230 - Medicaments containing insulin but not antibiotics, for therapeutic or prophylactic uses, not put up in measured doses or for retail sale

Country coverage:

  • Italy

Data coverage:

  • Market volume and value
  • Per Capita consumption
  • Forecast of the market dynamics in the medium term
  • Trade (exports and imports) in Italy
  • Export and import prices
  • Market trends, drivers and restraints
  • Key market players and their profiles

Reasons to buy this report:

  • Take advantage of the latest data
  • Find deeper insights into current market developments
  • Discover vital success factors affecting the market

This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.

In this report, you can find information that helps you to make informed decisions on the following issues:

  1. How to diversify your business and benefit from new market opportunities
  2. How to load your idle production capacity
  3. How to boost your sales on overseas markets
  4. How to increase your profit margins
  5. How to make your supply chain more sustainable
  6. How to reduce your production and supply chain costs
  7. How to outsource production to other countries
  8. How to prepare your business for global expansion

While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.

  1. 1. INTRODUCTION

    Making Data-Driven Decisions to Grow Your Business

    1. REPORT DESCRIPTION
    2. RESEARCH METHODOLOGY AND AI PLATFORM
    3. DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
    4. GLOSSARY AND SPECIFIC TERMS
  2. 2. EXECUTIVE SUMMARY

    A Quick Overview of Market Performance

    1. KEY FINDINGS
    2. MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO
  3. 3. MARKET OVERVIEW

    Understanding the Current State of The Market and Its Prospects

    1. MARKET SIZE
    2. MARKET STRUCTURE
    3. TRADE BALANCE
    4. PER CAPITA CONSUMPTION
    5. MARKET FORECAST TO 2030
  4. 4. MOST PROMISING PRODUCT

    Finding New Products to Diversify Your Business

    This Chapter is Available Only for the Professional Edition PRO
    1. TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
    2. BEST-SELLING PRODUCTS
    3. MOST CONSUMED PRODUCT
    4. MOST TRADED PRODUCT
    5. MOST PROFITABLE PRODUCT FOR EXPORT
  5. 5. MOST PROMISING SUPPLYING COUNTRIES

    Choosing the Best Countries to Establish Your Sustainable Supply Chain

    This Chapter is Available Only for the Professional Edition PRO
    1. TOP COUNTRIES TO SOURCE YOUR PRODUCT
    2. TOP PRODUCING COUNTRIES
    3. TOP EXPORTING COUNTRIES
    4. LOW-COST EXPORTING COUNTRIES
  6. 6. MOST PROMISING OVERSEAS MARKETS

    Choosing the Best Countries to Boost Your Exports

    This Chapter is Available Only for the Professional Edition PRO
    1. TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
    2. TOP CONSUMING MARKETS
    3. UNSATURATED MARKETS
    4. TOP IMPORTING MARKETS
    5. MOST PROFITABLE MARKETS
  7. 7. PRODUCTION

    The Latest Trends and Insights into The Industry

    1. PRODUCTION VOLUME AND VALUE
  8. 8. IMPORTS

    The Largest Import Supplying Countries

    1. IMPORTS FROM 2012–2023
    2. IMPORTS BY COUNTRY
    3. IMPORT PRICES BY COUNTRY
  9. 9. EXPORTS

    The Largest Destinations for Exports

    1. EXPORTS FROM 2012–2023
    2. EXPORTS BY COUNTRY
    3. EXPORT PRICES BY COUNTRY
  10. 10. PROFILES OF MAJOR PRODUCERS

    The Largest Producers on The Market and Their Profiles

    This Chapter is Available Only for the Professional Edition PRO
  11. LIST OF TABLES

    1. Key Findings In 2023
    2. Market Volume, In Physical Terms, 2012–2023
    3. Market Value, 2012–2023
    4. Per Capita Consumption In 2012-2023
    5. Imports, In Physical Terms, By Country, 2012–2023
    6. Imports, In Value Terms, By Country, 2012–2023
    7. Import Prices, By Country Of Origin, 2012–2023
    8. Exports, In Physical Terms, By Country, 2012–2023
    9. Exports, In Value Terms, By Country, 2012–2023
    10. Export Prices, By Country Of Destination, 2012–2023
  12. LIST OF FIGURES

    1. Market Volume, In Physical Terms, 2012–2023
    2. Market Value, 2012–2023
    3. Market Structure – Domestic Supply vs. Imports, In Physical Terms, 2012-2023
    4. Market Structure – Domestic Supply vs. Imports, In Value Terms, 2012-2023
    5. Trade Balance, In Physical Terms, 2012-2023
    6. Trade Balance, In Value Terms, 2012-2023
    7. Per Capita Consumption, 2012-2023
    8. Market Volume Forecast to 2030
    9. Market Value Forecast to 2030
    10. Products: Market Size And Growth, By Type
    11. Products: Average Per Capita Consumption, By Type
    12. Products: Exports And Growth, By Type
    13. Products: Export Prices And Growth, By Type
    14. Production Volume And Growth
    15. Exports And Growth
    16. Export Prices And Growth
    17. Market Size And Growth
    18. Per Capita Consumption
    19. Imports And Growth
    20. Import Prices
    21. Production, In Physical Terms, 2012–2023
    22. Production, In Value Terms, 2012–2023
    23. Imports, In Physical Terms, 2012–2023
    24. Imports, In Value Terms, 2012–2023
    25. Imports, In Physical Terms, By Country, 2023
    26. Imports, In Physical Terms, By Country, 2012–2023
    27. Imports, In Value Terms, By Country, 2012–2023
    28. Import Prices, By Country Of Origin, 2012–2023
    29. Exports, In Physical Terms, 2012–2023
    30. Exports, In Value Terms, 2012–2023
    31. Exports, In Physical Terms, By Country, 2023
    32. Exports, In Physical Terms, By Country, 2012–2023
    33. Exports, In Value Terms, By Country, 2012–2023
    34. Export Prices, By Country Of Destination, 2012–2023

Recommended reports

Free Data: Medicaments Containing Insulin But Not Antibiotics - Italy